Discover open access scientific publications

Search, annotate, share and cite publications

Publications by X. Zhang

JCSE01.18 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

Journal of Thoracic Oncology

English

P1.04-08 Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts From Lung Cancer Patients

Journal of Thoracic Oncology

English

P010 Relationship Between EGFR and KRAS Mutation and the Clinicopathologic Features of Early Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P3.01-084 Analysis on ALTER0303 Trial: ACECs Level May Correlate With Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC

Journal of Thoracic Oncology

English

P1.05-24 Clinical Characteristics and Prognostic Analysis of Multiple Primary Malignant Neoplasms in Patients With Lung Cancer

Journal of Thoracic Oncology

English

P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

Journal of Thoracic Oncology

English

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Journal of Thoracic Oncology

English

P1.03-34 Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI

Journal of Thoracic Oncology

English

P1.03-30 the Number of Mutated Repair Genes as Predictor for Tumor Mutation Burden of Lung Adenocarcinoma

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by X. Zhang

JCSE01.18 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

P1.04-08 Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts From Lung Cancer Patients

P010 Relationship Between EGFR and KRAS Mutation and the Clinicopathologic Features of Early Lung Adenocarcinoma

P3.01-084 Analysis on ALTER0303 Trial: ACECs Level May Correlate With Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC

P1.05-24 Clinical Characteristics and Prognostic Analysis of Multiple Primary Malignant Neoplasms in Patients With Lung Cancer

P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

P1.03-34 Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI

P1.03-30 the Number of Mutated Repair Genes as Predictor for Tumor Mutation Burden of Lung Adenocarcinoma